Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma

Neurosurgery. 2014 Dec;75(6):N9-10. doi: 10.1227/NEU.0000000000000580.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / genetics*
  • Cell Transformation, Neoplastic / drug effects*
  • Dacarbazine / analogs & derivatives
  • Dacarbazine / therapeutic use
  • Glioma / drug therapy
  • Glioma / genetics*
  • Humans
  • Mutation
  • Neoplasm Recurrence, Local / genetics*
  • Temozolomide

Substances

  • Antineoplastic Agents
  • Dacarbazine
  • Temozolomide